Friday, November 25, 2022

Novuson Reports Direct Therapeutic Ultrasound Improving Surgical Safety and Precision

Novuson announces the recent launch of their Regulation Crowdfunding raise. Join us in improving surgical safety and precision.

Novuson is focused on finishing validation studies for the regulatory clearance of our first-in-class Ultrastat 3mm MiniLS advanced energy sealer/divider. Energy based surgical instruments are used in most surgical procedures. They improve surgical efficiency.

We intend to revolutionize surgical safety and precision,” said Founder and CEO, Dr. Stuart Mitchell. “We at Novuson believe the Ultrastat 3mm MiniLS vessel sealer/divider will disrupt the surgical market, improving patient safety with DTU precision.”

With the help of StartEngine, we are excited to announce the commencement of our equity crowdfunding campaign. Equity crowdfunding allows companies like Novuson to raise capital from the public.  Investors will hold partial ownership in Novuson and will have the opportunity to profit if and when Novuson does well.

More information here.

SourceNovuson
Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.
spot_img
spot_img

Our Sister Publication

Biotechnology News Magazine

By using this website you agree to accept Medical Device News Magazine Privacy Policy